JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.17% |
| 2 | Technology | 12.62% |
| 3 | Healthcare | 10.37% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
2951
PUT
Nebius Group N.V.
NBIS
$69.3B
| $3.29M | ﹤0.01% |
100,000
-50,000
| -33% | -$1.69M |
|
2952
PUT
Unum
UNM
$14.7B
| $3.29M | ﹤0.01% |
+84,100
| New | +$3.14M |
|
|
DVAX
2953
DELISTED
Dynavax Technologies
DVAX
| $3.28M | ﹤0.01% |
264,669
+4,591
| +2% | +$62.1K |
|
2954
Natural Gas Services Group
NGS
$474M
| $3.27M | ﹤0.01% |
154,987
+13,247
| +9% | +$292K |
|
|
PRTK
2955
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.27M | ﹤0.01% |
337,110
+20,476
| +6% | +$207K |
|
|
SAND
2956
DELISTED
Sandstorm Gold
SAND
| $3.26M | ﹤0.01% |
873,704
-33,541
| -4% | -$136K |
|
|
TSC
2957
DELISTED
TriState Capital Holdings, Inc.
TSC
| $3.26M | ﹤0.01% |
118,148
+4,716
| +4% | +$135K |
|
2958
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.28B
| $3.26M | ﹤0.01% |
100,000
+97,175
| +3,440% | +$3.07M |
|
|
LCI
2959
DELISTED
Lannett Company, Inc.
LCI
| $3.25M | ﹤0.01% |
171,156
+146,086
| +583% | +$5.57M |
|
2960
World Acceptance Corp
WRLD
$875M
| $3.25M | ﹤0.01% |
28,378
-14,628
| -34% | -$1.68M |
|
|
IIN
2961
DELISTED
IntriCon Corporation
IIN
| $3.23M | ﹤0.01% |
57,566
+25,874
| +82% | +$1.51M |
|
|
CLVS
2962
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.23M | ﹤0.01% |
109,800
+8,100
| +8% | +$314K |
|
|
MNR
2963
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $3.22M | ﹤0.01% |
192,587
+47,771
| +33% | +$806K |
|
2964
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $3.22M | ﹤0.01% |
510,340
-608,843
| -54% | -$4.05M |
|
2965
Bruker
BRKR
$8.83B
| $3.21M | ﹤0.01% |
96,033
+24,048
| +33% | +$792K |
|
|
ATTU
2966
DELISTED
Attunity Ltd
ATTU
| $3.21M | ﹤0.01% |
169,686
+38,246
| +29% | +$650K |
|
2967
Seres Therapeutics
MCRB
$47.4M
| $3.2M | ﹤0.01% |
21,075
+1,265
| +6% | +$205K |
|
|
STBZ
2968
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $3.2M | ﹤0.01% |
105,963
-41,051
| -28% | -$1.33M |
|
|
MRLN
2969
DELISTED
Marlin Business Services Corp
MRLN
| $3.19M | ﹤0.01% |
110,729
-101
| -0.1% | -$2.95K |
|
|
TVRD
2970
Tvardi Therapeutics
TVRD
$22.1M
| $3.19M | ﹤0.01% |
3,704
-4,939
| -57% | -$3.57M |
|
|
SGYP
2971
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.19M | ﹤0.01% |
1,873,597
+93,320
| +5% | +$167K |
|
|
MRSN
2972
DELISTED
Mersana Therapeutics
MRSN
| $3.18M | ﹤0.01% |
12,734
+962
| +8% | +$322K |
|
|
RNET
2973
DELISTED
RigNet, Inc.
RNET
| $3.18M | ﹤0.01% |
156,354
-217,638
| -58% | -$3.27M |
|
2974
MiMedx Group
MDXG
$624M
| $3.18M | ﹤0.01% |
514,003
+26,133
| +5% | +$118K |
|
|
DCOM
2975
DELISTED
Dime Community Bancshares
DCOM
| $3.17M | ﹤0.01% |
177,315
-41,605
| -19% | -$771K |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.